NCT05841940View on ClinicalTrials.gov

Mass Balance Study of [14C]HLX208 in China Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

June 17, 2023

Primary Completion Date

July 15, 2023

Study Completion Date

December 15, 2023

Conditions

Mass Balance Study in Healthy Subjects

Interventions

DRUG

[14C]HLX208

Carbon-14 labeled HLX208

Trial Locations (1)

Unknown

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors

lead

Shanghai Henlius Biotech

INDUSTRY